Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Waxman

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Molecular Cancer|March 12, 2010
Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cellsPinar Uysal-Onganer, Yoshiaki Kawano, Mercedes Caro, et al.
Molecular Cancer Research : MCR|November 9, 2014
Survival Outcome and EMT Suppression Mediated by a Lectin Domain Interaction of Endo180 and CD147Mercedes Rodriguez-Teja, Julian H Gronau, Ai Minamidate, et al.
Breast Cancer Research and Treatment|December 8, 2014
Sphingosine kinase 1 contributes to leptin-induced STAT3 phosphorylation through IL-6/gp130 transactivation in oestrogen receptor-negative breast cancerHeba Alshaker, Qi Wang, Adam E Frampton, et al.
Breast Cancer Research : BCR|December 9, 2014
Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathwayHeba Alshaker, Jonathan Krell, Adam E Frampton, et al.
Cancer Research|October 21, 2010
FTY720 (fingolimod) sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1Dmitri Pchejetski, Torsten Bohler, Leyre Brizuela, et al.
Blood|July 14, 2011
CD3 limits the efficacy of TCR gene therapy in vivoMaryam Ahmadi, Judith W King, Shao-An Xue, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2004
Androgen receptor is targeted to distinct subcellular compartments in response to different therapeutic antiandrogensHayley C Whitaker, Sarah Hanrahan, Nick Totty, et al.
Oncogene|February 18, 2004
Androgens target prohibitin to regulate proliferation of prostate cancer cellsSimon C Gamble, Michael Odontiadis, Jonathan Waxman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2009
IL15 can reverse the unresponsiveness of Wilms' tumor antigen-specific CTL in patients with prostate cancerJudy W King, Sharyn Thomas, Fabrizio Corsi, et al.
Nature Communications|May 3, 2018
Frizzled-8 integrates Wnt-11 and transforming growth factor-β signaling in prostate cancerVirginia Murillo-Garzón, Irantzu Gorroño-Etxebarria, Malin Åkerfelt, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Molecular Cancer|March 12, 2010
Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cellsPinar Uysal-Onganer, Yoshiaki Kawano, Mercedes Caro, et al.
Molecular Cancer Research : MCR|November 9, 2014
Survival Outcome and EMT Suppression Mediated by a Lectin Domain Interaction of Endo180 and CD147Mercedes Rodriguez-Teja, Julian H Gronau, Ai Minamidate, et al.
Breast Cancer Research and Treatment|December 8, 2014
Sphingosine kinase 1 contributes to leptin-induced STAT3 phosphorylation through IL-6/gp130 transactivation in oestrogen receptor-negative breast cancerHeba Alshaker, Qi Wang, Adam E Frampton, et al.
Breast Cancer Research : BCR|December 9, 2014
Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathwayHeba Alshaker, Jonathan Krell, Adam E Frampton, et al.
Cancer Research|October 21, 2010
FTY720 (fingolimod) sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1Dmitri Pchejetski, Torsten Bohler, Leyre Brizuela, et al.
Blood|July 14, 2011
CD3 limits the efficacy of TCR gene therapy in vivoMaryam Ahmadi, Judith W King, Shao-An Xue, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2004
Androgen receptor is targeted to distinct subcellular compartments in response to different therapeutic antiandrogensHayley C Whitaker, Sarah Hanrahan, Nick Totty, et al.
Oncogene|February 18, 2004
Androgens target prohibitin to regulate proliferation of prostate cancer cellsSimon C Gamble, Michael Odontiadis, Jonathan Waxman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2009
IL15 can reverse the unresponsiveness of Wilms' tumor antigen-specific CTL in patients with prostate cancerJudy W King, Sharyn Thomas, Fabrizio Corsi, et al.
Nature Communications|May 3, 2018
Frizzled-8 integrates Wnt-11 and transforming growth factor-β signaling in prostate cancerVirginia Murillo-Garzón, Irantzu Gorroño-Etxebarria, Malin Åkerfelt, et al.
Pageof 8